Abstract
A series of novel 4-phenoxyquinoline derivatives containing 3-amino-2-cyano-acrylamide framework was designed and synthesized, and the in vitro cytotoxic activities of them against five cancer cell lines(HT-29, H460, A549, MKN-45, and U87MG) were evaluated. Most of the compounds exhibited moderate-to-significant cytotoxicity and high selectivity against one or more cell lines as compared with Foretinib. The studies of their preliminary structure-activity relationships(SARs) indicate that the compounds containing methyl groups, especially methyl groups at 4-position of the phenyl ring(moiety B) are more effective. Among them, compound 36 shows the most potent antitumor activities with IC50 values of 0.04, 0.09, 0.67, 0.39 and 1.10 μmol/L against HT-29, H460, A549, MKN-45 and U87MG cell lines, respectively.
Similar content being viewed by others
References
Bottaro D. P., Rubin J. S., Faletto D. L., Chan A. M., Kmiecik T. E., Vande Woude G. V., Aaronson S. A., Science, 1991, 251, 802
Yu H. Y., Tang Z. H., Song W. T., Deng M. X., Chen X. S., Chem. J. Chinese. Universitie, 2014, 35(5), 903
Wang S. Y., Chen B., Zhan Y. Q., Xu W. X., Li C. Y., Yang R. F., Zheng H., Yue P. B., Larsen S. H., Sun H. B., Yang X. M., Journal of Hepatolog, 2004, 41, 267
Corso S., Comoglio P. M., Giordano S., Trends Mol. Med., 2005, 11, 284
Riccardo F., Martina O., Maria F. D. R., Marina M., Carla D. G., Patrizia N., Giuseppe B., Katia S., Pier-Luigi L., Comoglio P. M., Oncogene, 1996, 12, 1697
Francesca D. B., Michela F., Andrea R., Cancer Ther., 2004, 213, 317
Underiner L. T., Herbertz T., Miknyoczki J. S., Anticancer Agent Med., 2010, 10, 7
Yakes F. M., Chen J., Tan J., Yamaguchi K., Shi Y. C., Yu P. W., Qian F., Chu F., Bentzien F., Cancilla B., Orf J., You A., Laird A. D., Engst S., Lee L., Lesch J., Chou Y. C., Joly A. H., Mol. Cancer Ther., 2011, 10, 2298
Kim K. S., Zhang L., Shmidt R., Cai Z. W., Wei D., Williams D. K., Lombardo L. J., Trainor G. L., Xie D., Zhang Y., An Y., Sack J. S., Tokarski J. S., Darienzo C., Kamath A., Marathe P., Zhang Y., Lippy J., Jeyaseelan R., Wautlet B., Henley B., Gullo-Brown J., Manne V., Hunt J. T., Fargoli J., Borzilleri R. M., J. Med. Chem., 2008, 51, 5330
Norman M. H., Liu L. B., Lee M., Xi N., Fellows I., D’Angelo N. D., Dominguez C., Rex K., Bellon S. F., Kim T. S., Dussault I., J. Med. Chem., 2012, 55, 1858
Liu L. B., Norman M. H., Lee M., Xi N., Siegmund A., Boezio A. A., Booker S., Choquette D., D’Angelo N. D., Germain J., Yang K., Yang Y. J., Zhang Y. H., Bellon S. F., Whittington D. A., Harmange J. C., Dominguez C., Kim T. S., Dussault I., J. Med. Chem., 2012, 55, 1868
Zhai X., He Y., Yang Z., Gong P., Chem. Res. Chinese. Universities, 2013, 29(1), 62
Li S., Huang Q., Liu Y. J., Zhang X. L., Liu S., He C., Gong P., Eur. J. Med. Chem., 2013, 64, 62
Qi B. H., Tao H. Y., Wu D., Bai J. Y., Shi Y. D., Gong P., Arch. harm. Chem. Life Sci., 2013, 346, 596
Qi B. H., Mi B., Zhai X., Xu Z. Y., Zhang X. L., Tian Z. R., Gong P., Bioorg. Med. Chem., 2013, 21, 5246
Li S., Zhao Y. F., Wang K. W., Gao Y. L., Han J. M., Cui B. B., Gong P., Bioorg. Med. Chem., 2013, 21, 2843
Li S., Jiang R., Qin M. Z., Liu H. C., Zhuang G. Y., Gong P., Arch. harm. Chem. Life Sci., 2013, 346, 521
Tang Q. D., Zhao Y. F., Du X. M., Chong L. E., Gong P., Guo C., Eur. J. Med. Chem., 2013, 69, 77
Tang Q. D., Zhang G. G., Du X. M., Zhu W. F., Li R. J., Lin H. F., Li P. C., Cheng M. S., Gong P., Zhao Y. F., Bioorg. Med. Chem., 2014, 22, 1236
Zhou S. G., Liao H. M., Liu M. M., Feng G. B., Fu B. L., Li R. J., Cheng M. S., Zhao Y. F., Gong P., Bioorg. Med. Chem., 2014, 22, 6438
George R. F., Eur. J. Med. Chem., 2012, 47, 377
Moustafa A. G., Abu-Hashem A. A., Arch. Pharm. Chem. Life Sci., 2011, 11, 170
Bellon S. F., Kaplan-Lefko P., Yang Y. J., Zhang Y. H., Moriguchi J., Rex K., Johnson C. W., Rose P. E., Long A. M., O’Connor A. B., Gu Y., Coxon A., Kim T. S., Tasker A., Burgess T. L., Dussault I., J. Biol. Chem., 2008, 283, 2675
Gong P., Liu Y. J., Zhao Y. F., Zhai X., Quinoline and Cinnoline Compounds as c-Met Kinase Inhibitors and Their Preparation, harmaceutical Compositions and Use in the Treatment of Hyperplastic Diseases, CN102643268A, 2012
Hernández S., Moreno I., San M. R., Gómez G., Herrero M. T., Domínguez E., J. Org. Chem., 2010, 75, 434
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supported by the Program for Liaoning Innovative Research Team in University, China(No.IRT1073).
Rights and permissions
About this article
Cite this article
Hu, H., Jiang, M., Xie, L. et al. Design, synthesis and pharmacological evaluation of novel 4-phenoxyquinoline derivatives as potential antitumor agents. Chem. Res. Chin. Univ. 31, 746–755 (2015). https://doi.org/10.1007/s40242-015-5166-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-015-5166-3